These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28320545)

  • 1. Haloperidol undermining gastroparesis symptoms (HUGS) in the emergency department.
    Ramirez R; Stalcup P; Croft B; Darracq MA
    Am J Emerg Med; 2017 Aug; 35(8):1118-1120. PubMed ID: 28320545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol Use in the Emergency Department for Gastrointestinal Symptoms: Nausea, Vomiting, and Abdominal Pain.
    Shahsavari D; Reznick-Lipina K; Malik Z; Weiner M; Jehangir A; Repanshek ZD; Parkman HP
    Clin Transl Gastroenterol; 2021 Jun; 12(6):e00362. PubMed ID: 34060494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of Haloperidol for Abdominal Pain in the Emergency Department (SHAPE).
    Knudsen-Lachendro K; Stith K; Vicarel LA; Harbert B; Fertel BS
    West J Emerg Med; 2021 May; 22(3):623-627. PubMed ID: 34125037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Controlled Double-blind Trial Comparing Haloperidol Combined With Conventional Therapy to Conventional Therapy Alone in Patients With Symptomatic Gastroparesis.
    Roldan CJ; Chambers KA; Paniagua L; Patel S; Cardenas-Turanzas M; Chathampally Y
    Acad Emerg Med; 2017 Nov; 24(11):1307-1314. PubMed ID: 28646590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Droperidol undermining gastroparesis symptoms (DRUGS) in the emergency department.
    Stirrup N; Jones G; Arthur J; Lewis Z
    Am J Emerg Med; 2024 Jan; 75():42-45. PubMed ID: 37897920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department.
    Wagner S; Hoppe J; Zuckerman M; Schwarz K; McLaughlin J
    Clin Toxicol (Phila); 2020 Jun; 58(6):471-475. PubMed ID: 31482758
    [No Abstract]   [Full Text] [Related]  

  • 7. Symptomatic management for gastroparesis: antiemetics, analgesics, and symptom modulators.
    Hasler WL
    Gastroenterol Clin North Am; 2015 Mar; 44(1):113-26. PubMed ID: 25667027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic gastroparesis.
    Koch KL; Calles-Escandón J
    Gastroenterol Clin North Am; 2015 Mar; 44(1):39-57. PubMed ID: 25667022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroparesis-associated refractory nausea treated with aprepitant.
    Fahler J; Wall GC; Leman BI
    Ann Pharmacother; 2012 Dec; 46(12):e38. PubMed ID: 23191934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antiemetics for nausea and vomiting of pregnancy in an emergency department setting.
    Mayhall EA; Gray R; Lopes V; Matteson KA
    Am J Emerg Med; 2015 Jul; 33(7):882-6. PubMed ID: 25921968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Vomiting Patient: Small Bowel Obstruction, Cyclic Vomiting, and Gastroparesis.
    Nagarwala J; Dev S; Markin A
    Emerg Med Clin North Am; 2016 May; 34(2):271-91. PubMed ID: 27133244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ondansetron use in the pediatric emergency department and effects on hospitalization and return rates: are we masking alternative diagnoses?
    Sturm JJ; Hirsh DA; Schweickert A; Massey R; Simon HK
    Ann Emerg Med; 2010 May; 55(5):415-22. PubMed ID: 20031265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroparesis Updates on Pathogenesis and Management.
    Liu N; Abell T
    Gut Liver; 2017 Sep; 11(5):579-589. PubMed ID: 28535580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment of nausea and vomiting associated with gastroparesis: antiemetics, prokinetics, tricyclics.
    Stapleton J; Wo JM
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):57-72, vi. PubMed ID: 19232281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency department ondansetron use in children with type 1 diabetes mellitus and vomiting.
    Leung JS; Perlman K; Rumantir M; Freedman SB
    J Pediatr; 2015 Feb; 166(2):432-8. PubMed ID: 25454931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of symptoms, syndrome and disease: treatment of refractory diabetic gastroparesis.
    Li JL; Li M; Pang B; Zhou Q; Tian JX; Liu HX; Zhao XY; Tong XL
    World J Gastroenterol; 2014 Jul; 20(26):8674-80. PubMed ID: 25024625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis.
    Soykan I; Sarosiek I; McCallum RW
    Am J Gastroenterol; 1997 Jun; 92(6):976-80. PubMed ID: 9177513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroparesis: A Review of Current Diagnosis and Treatment Options.
    Stein B; Everhart KK; Lacy BE
    J Clin Gastroenterol; 2015 Aug; 49(7):550-8. PubMed ID: 25874755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol for treatment of cannabinoid hyperemesis syndrome.
    Hickey JL; Witsil JC; Mycyk MB
    Am J Emerg Med; 2013 Jun; 31(6):1003.e5-6. PubMed ID: 23583118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of gastroparesis.
    Reddymasu SC; McCallum RW
    Expert Opin Pharmacother; 2009 Feb; 10(3):469-84. PubMed ID: 19191682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.